L-arginine
DrugInitiation of L-arginine within 3 postoperative days
NCT Number: NCT07718373
Acute kidney injury (AKI) is common after cardiac surgery, yet effective protective strategies remain limited. L-arginine is the substrate for endogenous nitric oxide (NO) synthesis and may improve renal perfusion and endothelial function. investigators emulated a target trial to evaluate whether early perioperative L-arginine was associated with a lower risk of AKI after cardiac surgery.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
·adults admitted to the ICU after CPB-assisted cardiac surgery
Exclusion criteria
Initiation of L-arginine within 3 postoperative days
Time frame: within 7 postoperative days
defined by KDIGO criteria
Time frame: within 7 postoperative days
defined by KDIGO criteria
Time frame: up to 48 weeks
in-hospital mortality.
Contact information is provided by the study sponsor or research team.
Xijing Hospital
Other
Early Postoperative L-arginine and Acute Kidney Injury After Cardiac Surgery: a Target Trial Emulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07751913
Acute Kidney Injury, Female Urogenital Diseases
View Trial DetailsNCT07751874
Acute Kidney Injury, Female Urogenital Diseases
Edegem, Antwerp, Belgium
View Trial DetailsNCT07738328
Acute Kidney Injury, Cardiac Surgical Procedures
Guangzhou, Guangdong, China
View Trial DetailsNCT07739290
Acute Kidney Injury, Female Urogenital Diseases
View Trial Details